Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M208Revenue $M7.5Net Margin (%)-591.0Altman Z-Score-3.9
Enterprise Value $M227EPS $-0.6Operating Margin %-784.6Piotroski F-Score4
P/E(ttm)--Beneish M-Score-1.6Pre-tax Margin (%)-800.9Higher ROA y-yY
Price/Book13.710-y EBITDA Growth Rate %32.7Quick Ratio3.3Cash flow > EarningsY
Price/Sales23.15-y EBITDA Growth Rate %45.2Current Ratio3.3Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-61.8Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-214.7Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M94.9ROIC % (ttm)--Gross Margin Increase y-yY

Gurus Latest Trades with BTX

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

BTX is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


BTX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BROADWOOD PARTNERS LPDirector, 10% Owner 2016-01-20Buy300,000$2.35-6.81view
KINGSLEY ALFRED DSee Remarks, 10% Owner 2016-01-20Sell300,000$2.35-6.81view
FARRELL STEPHEN CDirector 2015-11-06Buy50,000$3.83-42.82view
Russell Angus C.Director 2015-11-06Buy50,000$3.83-42.82view
KINGSLEY ALFRED DSee Remarks, 10% Owner 2015-11-06Sell100,000$3.83-42.82view
ANDREWS DEBORAH JDirector 2015-08-26Buy2,000$2.82-22.34view
Cartt Stephen LaHueDirector 2015-08-18Buy75,000$2.8-21.79view
Russell Angus C.Director 2014-12-12Sell0$0-21.79view
Cartt Stephen LaHueDirector 2014-11-04Sell0$0-21.79view
FARRELL STEPHEN CDirector 2014-10-08Buy32,050$3.12-29.81view

Quarterly/Annual Reports about BTX:

News about BTX:

Articles On GuruFocus.com
Weekly CFO Buys Highlight: BTX, CWST, BKSC, STAG Jun 27 2011 
Weekly CEO Buys Highlight: PCYC, HLX, FSC, CREG, BTX Jun 25 2011 

More From Other Websites
BioTime, Inc. to Present at Three Investor Conferences in February Feb 01 2016
BioTime, Inc. to Present at Three Investor Conferences in February Feb 01 2016
BIOTIME INC Files SEC form 8-K, Entry into a Material Definitive Agreement Jan 27 2016
LifeMap Sciences, a Subsidiary of BioTime, Announces the Launch of TGex™, the Knowledge-Driven NGS... Jan 20 2016
Adjustments Affecting BioTime, Inc. Common Share Purchase Warrants Expiring October 1, 2018 Jan 12 2016
BIOTIME INC Files SEC form 8-K, Material Modification to Rights of Security Holders, Financial... Jan 12 2016
Adjustments Affecting BioTime, Inc. Common Share Purchase Warrants Expiring October 1, 2018 Jan 12 2016
BIOTIME INC Financials Jan 07 2016
BioTime, Inc. breached its 50 day moving average in a Bearish Manner : January 5, 2016 Jan 05 2016
OncoCyte Corporation Initiates Trading on the NYSE MKT Jan 04 2016
BioTime Completes Distribution of Approximately 4.75 Million Shares of OncoCyte Corporation Common... Dec 31 2015
BIOTIME INC Files SEC form 8-K, Other Events Dec 31 2015
BioTime Completes Distribution of Approximately 4.75 Million Shares of OncoCyte Corporation Common... Dec 31 2015
BIOTIME INC Files SEC form 8-K, Other Events Dec 30 2015
BioTime Announces “When-Issued” Trading of Subsidiary OncoCyte Corporation in Connection With... Dec 30 2015
BioTime Announces “When-Issued” Trading of Subsidiary OncoCyte Corporation in Connection With... Dec 30 2015
OncoCyte Appoints Dr. Andrew J. Last to Its Board of Directors Dec 23 2015
BioTime, Inc. Earnings Analysis: Q3, 2015 By the Numbers Dec 22 2015
Coverage initiated on BioTime by Oppenheimer Dec 22 2015
Stephen C. Farrell Appointed to STAAR Surgical Board of Directors Dec 17 2015

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK